Philips Trilogy ventilators that were reworked as part of a June 2021 recall may have new issues, the US Food and Drug Administration announced on 17 November.
The ventilators were initially recalled because the polyurethane foam used in them could degrade during use, potentially releasing particles or hazardous gases that users might inhale. The FDA labeled...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?